Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against Mycobacterium massiliensis

作者：Marques Neto Lazaro M; Trentini Monalisa M; das Neves Rogerio C; Resende Danilo P; Procopio Victor O; da Costa Adeliane C; Kipnis Andre; Mortari Marcia R; Schwartz Elisabeth F; Junqueira Kipnis Ana Paula^*

来源：Toxins, 2018, 10(6): 219.

DOI：10.3390/toxins10060219

• antimicrobial peptide
• mycobacteria inhibition
• Mycobacterium
• monocyte
• neutrophil

Mycobacterium massiliense is a rapid growing, multidrug-resistant, non-tuberculous mycobacteria that is responsible for a wide spectrum of skin and soft tissue infections, as well as other organs, such as the lungs. Antimicrobial peptides had been described as broad-spectrum antimicrobial, chemotactic, and immunomodulator molecules. In this study we evaluated an antimicrobial peptide derived from scorpion Tityus obscurus as an anti-mycobacterial agent in vitro and in vivo. Bioinformatics analyses demonstrated that the peptide ToAP2 have a conserved region similar to several membrane proteins, as well as mouse cathelicidin. ToAP2 inhibited the growth of four M. massiliense strains (GO01, GO06, GO08, and CRM0020) at a minimal bactericidal concentration (MBC) of 200 mu M. MBC concentration used to treat infected macrophages was able to inhibit 50% of the bacterial growth of all strains. ToAP2 treatment of infected mice with bacilli reduced the bacterial load in the liver, lung, and spleen, similarly to clarithromycin levels (90%). ToAP2 alone recruited monocytes (F4/80(low) Gr1), neutrophils (F4/80(-) Gr1), and eosinophils (F4/80+ Gr1+). ToAP2, together with M. massiliense infection, was able to increase F4/80(low) and reduce the percentage of F4/80(high) macrophages when compared with infected and untreated mice. ToAP2 has in vitro anti-microbial activity that is improved in vivo due to chemotactic activity.

• 出版日期2018-6